Skip to content

Clinical trials

Alzheimer Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Canada Clear all

307 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20024
20034
20048
20053
20067
200710
200810
200919
20107
20115
201215
201313
201417
201512
201622
201715
201814
201913
20209
202116
202225
202313
202412
202521
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed158
Terminated62
Recruiting46
Active, not recruiting18
Unknown status15
Withdrawn3
Not yet recruiting2
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche17
Sunnybrook Health Sciences Centre16
Eli Lilly and Company14
Pfizer11
University Health Network, Toronto10
GlaxoSmithKline9
Centre for Addiction and Mental Health8
McMaster University8
Bristol-Myers Squibb7
H. Lundbeck A/S6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease307
Dementia92
Cognitive Dysfunction53
Psychomotor Agitation17
Brain Diseases14
Neurodegenerative Diseases14
Mental Disorders12
Nervous System Diseases12
Neurocognitive Disorders12
Central Nervous System Diseases11

Trials

Showing 51 to 75 of 307. Each trial links to its page on Pharma Observatory.

207 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.